Incidence of endophthalmitis following intravitreal Bevacizumab injection at a tertiary care hospital in Eastern Province of Saudi Arabia

The aim of this communication is to report the incidence of endophthalmitis following the use of intravitreal Bevacizumab (IVB) at a tertiary care hospital in the Eastern province of Saudi Arabia. A total of 2769 intravitreal Bevacizumab injections were carried out between January 2009 and April 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheema, Rizwan A., Alshihry, Ahmad M., Cheema, Haider R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398804/
https://www.ncbi.nlm.nih.gov/pubmed/25892933
http://dx.doi.org/10.1016/j.sjopt.2014.11.001
_version_ 1782366856785428480
author Cheema, Rizwan A.
Alshihry, Ahmad M.
Cheema, Haider R.
author_facet Cheema, Rizwan A.
Alshihry, Ahmad M.
Cheema, Haider R.
author_sort Cheema, Rizwan A.
collection PubMed
description The aim of this communication is to report the incidence of endophthalmitis following the use of intravitreal Bevacizumab (IVB) at a tertiary care hospital in the Eastern province of Saudi Arabia. A total of 2769 intravitreal Bevacizumab injections were carried out between January 2009 and April 2014. During this period, one case of endophthalmitis following IVB injection occurred. The overall incidence of clinical endophthalmitis was 0.036% (1/2769; 95% confidence interval: 0.0001–0.002%). This compares favorably with studies reported from other parts of the world.
format Online
Article
Text
id pubmed-4398804
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-43988042015-04-17 Incidence of endophthalmitis following intravitreal Bevacizumab injection at a tertiary care hospital in Eastern Province of Saudi Arabia Cheema, Rizwan A. Alshihry, Ahmad M. Cheema, Haider R. Saudi J Ophthalmol Short Communication The aim of this communication is to report the incidence of endophthalmitis following the use of intravitreal Bevacizumab (IVB) at a tertiary care hospital in the Eastern province of Saudi Arabia. A total of 2769 intravitreal Bevacizumab injections were carried out between January 2009 and April 2014. During this period, one case of endophthalmitis following IVB injection occurred. The overall incidence of clinical endophthalmitis was 0.036% (1/2769; 95% confidence interval: 0.0001–0.002%). This compares favorably with studies reported from other parts of the world. Elsevier 2015 2014-11-26 /pmc/articles/PMC4398804/ /pubmed/25892933 http://dx.doi.org/10.1016/j.sjopt.2014.11.001 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Short Communication
Cheema, Rizwan A.
Alshihry, Ahmad M.
Cheema, Haider R.
Incidence of endophthalmitis following intravitreal Bevacizumab injection at a tertiary care hospital in Eastern Province of Saudi Arabia
title Incidence of endophthalmitis following intravitreal Bevacizumab injection at a tertiary care hospital in Eastern Province of Saudi Arabia
title_full Incidence of endophthalmitis following intravitreal Bevacizumab injection at a tertiary care hospital in Eastern Province of Saudi Arabia
title_fullStr Incidence of endophthalmitis following intravitreal Bevacizumab injection at a tertiary care hospital in Eastern Province of Saudi Arabia
title_full_unstemmed Incidence of endophthalmitis following intravitreal Bevacizumab injection at a tertiary care hospital in Eastern Province of Saudi Arabia
title_short Incidence of endophthalmitis following intravitreal Bevacizumab injection at a tertiary care hospital in Eastern Province of Saudi Arabia
title_sort incidence of endophthalmitis following intravitreal bevacizumab injection at a tertiary care hospital in eastern province of saudi arabia
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398804/
https://www.ncbi.nlm.nih.gov/pubmed/25892933
http://dx.doi.org/10.1016/j.sjopt.2014.11.001
work_keys_str_mv AT cheemarizwana incidenceofendophthalmitisfollowingintravitrealbevacizumabinjectionatatertiarycarehospitalineasternprovinceofsaudiarabia
AT alshihryahmadm incidenceofendophthalmitisfollowingintravitrealbevacizumabinjectionatatertiarycarehospitalineasternprovinceofsaudiarabia
AT cheemahaiderr incidenceofendophthalmitisfollowingintravitrealbevacizumabinjectionatatertiarycarehospitalineasternprovinceofsaudiarabia

Ejemplares similares